160 related articles for article (PubMed ID: 14735693)
1. Paclitaxel and concurrent radiation in upper gastrointestinal cancers.
Constantinou M; Tsai JY; Safran H
Cancer Invest; 2003; 21(6):887-96. PubMed ID: 14735693
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
Safran H; Akerman P; Cioffi W; Gaissert H; Joseph P; King T; Hesketh PJ; Wanebo H
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):53-7. PubMed ID: 10210540
[TBL] [Abstract][Full Text] [Related]
3. Weekly paclitaxel as a radiation sensitizer for locally advanced gastric and pancreatic cancers: the Brown University Oncology Group experience.
Sikov WM; Safran H
Front Biosci; 1997 May; 2():e21-7. PubMed ID: 9206986
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel as a radiation sensitizer for locally advanced pancreatic cancer.
Safran H; Rathore R
Crit Rev Oncol Hematol; 2002 Jul; 43(1):57-62. PubMed ID: 12098607
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study.
Safran H; King TP; Choy H; Hesketh PJ; Wolf B; Altenhein E; Sikov W; Rosmarin A; Akerley W; Radie-Keane K; Cicchetti G; Lopez F; Bland K; Wanebo HJ
J Clin Oncol; 1997 Mar; 15(3):901-7. PubMed ID: 9060526
[TBL] [Abstract][Full Text] [Related]
6. Taxanes in combined-modality therapy for solid tumors.
Choy H
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):23-38. PubMed ID: 10550824
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12.
Rich T; Harris J; Abrams R; Erickson B; Doherty M; Paradelo J; Small W; Safran H; Wanebo HJ
Am J Clin Oncol; 2004 Feb; 27(1):51-6. PubMed ID: 14758134
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel and concurrent radiation for locally advanced pancreatic carcinoma.
Safran H; Cioffi W; Iannitti D; Mega A; Akerman P
Front Biosci; 1998 Nov; 3():E204-6. PubMed ID: 9792903
[TBL] [Abstract][Full Text] [Related]
9. Role of p53 and p16 gene alterations in determining response to concurrent paclitaxel and radiation in solid tumor.
King TC; Estalilla OC; Safran H
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):4-11. PubMed ID: 10210535
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy.
Brenner B; Ilson DH; Minsky BD; Bains MS; Tong W; Gonen M; Kelsen DP
J Clin Oncol; 2004 Jan; 22(1):45-52. PubMed ID: 14701767
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: a phase I study.
Dipetrillo T; Milas L; Evans D; Akerman P; Ng T; Miner T; Cruff D; Chauhan B; Iannitti D; Harrington D; Safran H
Am J Clin Oncol; 2006 Aug; 29(4):376-9. PubMed ID: 16891865
[TBL] [Abstract][Full Text] [Related]
12. [Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer].
Zhang P; Xie CY; Wu SX
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):773-7. PubMed ID: 18396692
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel and concurrent radiation for gastric cancer.
Safran H; Wanebo HJ; Hesketh PJ; Akerman P; Ianitti D; Cioffi W; DiPetrillo T; Wolf B; Koness J; McAnaw R; Moore T; Chen MH; Radie-Keane K
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):889-94. PubMed ID: 10705010
[TBL] [Abstract][Full Text] [Related]
14. COX-2 inhibitors as radiation sensitizers for upper GI tract cancers: esophagus, stomach, and pancreas.
Rich TA; Shepard R
Am J Clin Oncol; 2003 Aug; 26(4):S110-3. PubMed ID: 12902867
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel in the treatment of esophageal cancer.
Weiner LM
Semin Oncol; 1999 Feb; 26(1 Suppl 2):106-8. PubMed ID: 10190790
[TBL] [Abstract][Full Text] [Related]
16. Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer.
Blanke CD; Choy H; Teng M; Beauchamp RD; Leach S; Roberts J; Washington K; Johnson DH
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):43-52. PubMed ID: 10210539
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Ajani JA; Ilson DH; Kelsen DP
Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-based regimens as first-line treatment in advanced gastric cancer.
Guo Z; Wang X; Lin R; Chen L; Fan N; Chen Y; Lin J; Yu J
J Chemother; 2015 Feb; 27(2):94-8. PubMed ID: 24548091
[TBL] [Abstract][Full Text] [Related]
19. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel and concurrent radiation for locally advanced pancreatic cancer.
Safran H; Moore T; Iannitti D; Dipetrillo T; Akerman P; Cioffi W; Harrington D; Quirk D; Rathore R; Cruff D; Vakharia J; Vora S; Savarese D; Wanebo H
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1275-9. PubMed ID: 11286834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
